# Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut Microbiota

> **NCT02061124** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 50 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Sevelamer 1600 mg TID for 7 days
- **DRUG:** Placebo 1600 mg TID for 7 days

## Key facts

- **NCT ID:** NCT02061124
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02061124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02061124, "Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut Microbiota". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02061124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*